Global Patent Index - EP 0822815 A4

EP 0822815 A4 19980401 - A METHOD OF MAKING PHARMACEUTICALLY ACTIVE TAXANES ORALLY BIOAVAILABLE

Title (en)

A METHOD OF MAKING PHARMACEUTICALLY ACTIVE TAXANES ORALLY BIOAVAILABLE

Title (de)

VERFAHREN ZUR ORALEN BIOVERFÜGBARKEITMACHUNG PHARMAZEUTISCH AKTIVER TAXANE

Title (fr)

PROCEDE PERMETTANT DE RENDRE ACTIFS DU POINT DE VUE PHARMACEUTIQUE DES TAXANES ASSIMILABLES PAR VOIE ORALE

Publication

EP 0822815 A4 19980401 (EN)

Application

EP 97901977 A 19970115

Priority

  • US 9700405 W 19970115
  • US 1091696 P 19960131

Abstract (en)

[origin: WO9727855A1] The present invention concerns a method of making pharmacologically active taxane compounds orally bioavailable. More particularly, the invention provides enhancing the oral absorption of pharmacologically active taxane compounds by co-administering a taxane with cinchonine.

IPC 1-7

A61K 31/44; A61K 31/47

IPC 8 full level

A61K 31/49 (2006.01)

CPC (source: EP)

A61K 31/49 (2013.01)

C-Set (source: EP)

  1. A61K 31/49 + A61K 31/335
  2. A61K 31/49 + A61K 2300/00

Citation (search report)

[X] WO 9214467 A1 19920903 - DEBIOPHARM SA [CH], et al

Citation (examination)

  • LUM ET AL.: "MDR expression in normal tissues : pharmacologic implications for the clinical use of P-glycoprotein inhibitors.", DRUG RESISTANCE IN CLINICAL ONCOLOGY AND HAEMATOLOGY, vol. 9, no. 2, - 1995, pages 319 - 336, XP009055111
  • See also references of WO 9727855A1

Designated contracting state (EPC)

AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

DOCDB simple family (publication)

WO 9727855 A1 19970807; AU 1575897 A 19970822; AU 701607 B2 19990204; CA 2221444 A1 19970807; EP 0822815 A1 19980211; EP 0822815 A4 19980401

DOCDB simple family (application)

US 9700405 W 19970115; AU 1575897 A 19970115; CA 2221444 A 19970115; EP 97901977 A 19970115